Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > Asia > Russia
Category: All Categories > Life Sciences > Pharmaceuticals > Research & Development
(9 reports matching your criteria)
 
Rheumatoid Arthritis in Brazil, Russia, and China – How Are Payers and Prescribers Promoting or Limiting Growth in the Biologics Markets
11/30/2012 | published by: Decision Resources
... by a growing prevalent population with greater access to medical care and by rheumatologists’ increasing use of more aggressive treatments. Increased government spending on healthcare and improved penetration of biological agents make this an attractive ...  |  read more...
$10,000.00
Special Report: Opportunities in Emerging Markets—Developing Asia
8/1/2011 | published by: Decision Resources
... Brazil, Russia, India, China, Mexico, and Turkey (BRIC-MT) for their emerging market strategies. Two of these markets, China and India, are in developing Asia. Other small and midsize developing Asian markets also offer significant opportunities ...  |  read more...
$9,200.00
Clinical Trials Market in Russia
5/1/2011 | published by: RNCOS
... effectively broadened its attractiveness as one of the leading destinations for conducting clinical trials. Russia is offering a tough competition to other countries in the region in the clinical trials market. This statement can be ...  |  read more...
$1,000.00
Pharmaceutical Industry in Russia
4/1/2011 | published by: Aruvian's R'search
... 19th century. The invention of penicillin can yet be recognized as a major milestone for the emergent industry which firmly consolidated its R&D efforts in the 1950’s. Further in the 1960’s the patent regulation support ...  |  read more...
$300.00
The Market for Pharmaceuticals in Brazil, Russia, India & China
3/31/2011 | published by: Espicom Healthcare Intelligence
... forecasts to 2014 are provided, plus free quarterly-updated market outlook reports on each country, keeping you up to date with developments for a full year. Please note, this file is delivered as an Zip file.  |  read more...
$3,490.00
Russian Pharma Sector Forecast to 2013
3/1/2011 | published by: RNCOS
... This high growth rate can be attributed to the development incentives announced by the government for the state drugs segment. The government is also taking the required steps to boost the domestic pharma industry and ...  |  read more...
$800.00
Emerging Markets Clinical Development Series Brazil, Russia, India and China (BRIC)
11/1/2010 | published by: Cutting Edge Information
... (or recruitment challenges) that plague studies in North America and Western Europe, unparalleled access to untapped patient populations, and new opportunities to meet the growing medical needs of these countries. Despite vast promise as the ...  |  read more...
$7,695.00
Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
5/25/2010 | published by: Datamonitor
... coverage coupled with a growing affluent middle class and private sector have turned countries like Brazil, Russia or India into a promising commercial opportunity. Scope Analysis of current HIV market dynamics across Brazil, Russia and ...  |  read more...
$3,800.00
Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel.)
11/1/2007 | published by: Kalorama Information
... problems. This provides an opportunity for BRIC countries and other developing regions to grab a piece of the clinical trial market. Countries such as India and China have a vast population who are interested in ...  |  read more...
Buy by the section  | 
$1,500.00